Randomized Controlled Trial
Copyright ©The Author(s) 2023.
World J Gastrointest Oncol. May 15, 2023; 15(5): 878-891
Published online May 15, 2023. doi: 10.4251/wjgo.v15.i5.878
Table 3 All polyps analysis of both group

IEE group (n = 2113)
WLI group (n = 2098)
P value
Relative risk (95%CI)
PDR882/2113 (41.7)757/2098 (36.1)0.011.16 (1.07-1.25)
All polyps15881319
Inflammatory polyp426 (26.8)341 (25.9)0.551.04 (0.92-1.17)
Hyperplastic polyp179 (11.3)150 (11.4)0.930.99 (0.81-1.22)
Adenoma polyp690 (43.5)590 (44.7)0.490.97 (0.90-1.06)
Sessile serrated adenoma10 (0.6)11 (0.8)0.520.76 (0.32-1.77)
Chronic inflammation262 (16.5)211 (16.0)0.711.03 (0.87-1.22)
Cancer16 (1.0)13 (1.0)0.951.02 (0.49-2.12)
Others5 (0.3)3 (0.2)0.7411.38 (0.33-5.78)
Adenoma per colonoscopy0.33 ± 0.680.28 ± 0.620.06
Adenoma polyp690590
Size0.44
≤ 5 mm338 (49.0)294 (49.8)0.98 (0.88-1.10)
6-9 mm211 (30.6)163 (27.6)1.11 (0.93-1.32)
≥ 10 mm141 (20.4)133 (22.5)0.91 (0.74-1.12)
Shape0.39
Pedunculated72 (10.4)76 (12.9)0.81 (0.60-1.10)
Subpedunculated186 (27.0)154 (26.1)1.03 (0.86-1.24)
Flat432 (62.6)360 (61.0)1.03 (0.94-1.12)
Pathology0.80
Tubular adenoma670 (97.1)569 (96.4)1.01 (0.99-1.03)
Tubulovillous adenoma18 (2.6)19 (3.2)0.81 (0.43-1.53)
Villous adenoma2 (0.3)2 (0.3)0.86 (0.12-6.05)
Site0.50
Left258 (37.4)236 (40.0)0.94 (0.81-1.07)
Right357 (51.7)299 (50.7)1.02 (0.92-1.14)
Rectum75 (10.9)55 (9.3)1.17 (0.84-1.62)